Back to results
US 2001/0018530 A1Published application
Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration
AssigneeBayer Aktiengesellschaft
InventorsThomas Fahrig, Irene Gerlach, Ervin Horvath, Reinhard Jork
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of substituted aminomethyl-chromans for the treatment of neuronal degeneration and for the promotion of neuronal regeneration in cerebral injuries and chronic disorders of the nervous system.
Claims8
Use of substituted arninomethyl-chromans of the following formula (I) 7
- in which
- R1 represents hydrogen,
- R2 represents hydrogen, hydroxyl or a radical of the formula —OCH3, —OCH2CH3, —OCH(CH3)2 or —OCH2C(CH3)2—Cl or
- R1 and R2 together form a radical of the formula 8
- R3 represents cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or o-benzenesulphirnidyl and
- n is selected from 1, 2, 3, 4 or 5,
- and their optical isomers and pharmaceutically acceptable salts, for the production of a medicament for the treatment of neurodegenerative disorders and for the promotion of neuronal regeneration.
4 more elements
Dependencies are inferred from the claim text.